Inline Pharmaceuticals Private Limited, a active private limited company, was established on 20 December 2019 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24117TG2019PTC137780. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹7.00 M and a paid-up capital of ₹4.00 M.
It upholds a compliant status. Its leadership includes Srilakshmi Yarlagadda (Director), Trinath Tummepalli (Director). Past directors included Balayogiswara Rao Peddinti, Rama Rao Tummepally, Shashidhar Reddy Kandadi. It holds ₹2.91 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.B-5, Tie Phase-Ii Balanagar, Hyderabad, Telangana, 500037.
U24117TG2019PTC137780
137780
20 December 2019
₹7.00 M
₹4.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Inline Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Srilakshmi Yarlagadda | Director | 20 Dec 2019 | Current |
| Trinath Tummepalli | Director | 09 Mar 2022 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 10 Feb 2022 | Past |
| Pramod Abcsdd | Director | 12 Feb 2022 | Past |
| Pramod Abcsdd | Director | 12 Feb 2022 | Past |
| Pramod Abcsdd | Director | 25 Feb 2023 | Past |
| Pramod Abcsdd | Director | 12 Feb 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Inline Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 944.65% increase. The company also saw a substantial improvement in profitability, with a 138.26% increase in profit. The company's net worth Soared by an impressive increase of 40.55%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Inline Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹29,065,289.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2024 | State Bank Of India | ₹2.00 Cr | Open |
| 28 Sep 2024 | Others | ₹9.07 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Inline Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Inline Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Inline Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Inline Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Progress on Inline Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
A charge with State Bank Of India amounted to Rs. 20.00 M with Charge ID 101013586 was registered on 21 Nov 2024. was recorded as a recent event.
A charge with Others amounted to Rs. 9.07 M with Charge ID 101020940 was registered on 28 Sep 2024. was recorded as a recent event.
Trinath Tummepalli was appointed as a Director was appointed as a Director on 09 Mar 2022 & has been associated with this company since 3 years 10 months . was recorded as a recent event.
The activity Srilakshmi Yarlagadda was appointed as a Director was appointed as a Director on 20 Dec 2019 & has been associated with this company since 6 years 25 days . was completed.
The CIN of Inline Pharmaceuticals Private Limited is U24117TG2019PTC137780.
Inline Pharmaceuticals Private Limited is headquartered at Plot No.B-5, Tie Phase-Ii Balanagar, Hyderabad, Telangana, 500037.
Inline Pharmaceuticals Private Limited was incorporated on 20 December 2019.
The current directors of Inline Pharmaceuticals Private Limited are
The primary industry of Inline Pharmaceuticals Private Limited is Manufacturing.
Inline Pharmaceuticals Private Limited is unlisted.
The authorized capital of Inline Pharmaceuticals Private Limited is ₹7.00 M, and the paid-up capital is ₹4.00 M.
The compliance status of Inline Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX